Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Shionogi and BMS to collaborate on irbesartan

May 17, 1996

New angiotensin II antagonist presented by Bayer at German pharmacology meeting

May 17, 1996

Endothelin antagonists reported by Shionogi

May 17, 1996

Advisory committee refuses to recommend Coreg approval for CHF

May 10, 1996

Structure revealed for UK-1745

May 10, 1996

Structure disclosed for KCB-328

May 10, 1996

More Na+/H+-exchange inhibitors from Hoechst

May 10, 1996

Na+/H+-exchange inhibitors revealed by E. Merck

May 10, 1996

Cylexin phase II results announced

May 10, 1996

Zynaxis to develop Zyn-Linker form of paclitaxel for restenosis Rx

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...